An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action
By R. Shank, J. F. Gardocki, A. Streeter, B. Maryanoff. Epilepsia, 2000
672 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Molecular Biology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/31becef99e35c68d1c34ee6551d12ffbdf999080
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Molecular Biology
Citations in the corpus
- Topiramate for migraine prevention: a randomized controlled trial. (2004, neutral): “Fatigue 10 (9) 1 (1) 22 (19) 5 (4) 17 (14) 9 (8) 21 (18) 2 (2)”
- TMS and drugs revisited 2014. (2015, background): “…at least four different modes of action that may explain its seizure suppressing efficiency: sodium channel blockade, blockade of voltage-gated L-type calcium channels, enhancement of GABAergic transmission, blockade of non-NMDA receptor mediated glutamatergic transmission (Shank et al., 2000).”
- TMS and drugs. (2004, background): “Several different modes of action were identified at the cellular level (for review, (Shank et al., 2000)).”